Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2006
06/13/2006US7060816 Detection of fungal pathogens using the polymerase chain reaction
06/13/2006US7060815 Breeding hops with transformation techniques and molecular selection techniques
06/13/2006US7060814 Nucleotide sequences for use as tools in human therapeutics and diagnostics
06/13/2006US7060812 Nucleotide sequence coding polypeptide for use in the treatment and diagnosis of nervous system disorders
06/13/2006US7060811 Isolation; cloning; hybrid anticancer agents; protein genetic mapping of human chromosome
06/13/2006US7060809 Locked nucleic acid units may be used in a wide variety of applications, such as PCR primers, sequencing, synthesis of antisense oligonucleotides, diagnostics and the like
06/13/2006US7060808 Epidermal growth factor; nucleic acids, protein which binds to epidermal growth factor receptors; genetic engineering
06/13/2006US7060690 For therapy of cancer
06/13/2006US7060500 Single-stranded oligodeoxynucleotide mutational vectors
06/13/2006US7060499 causes recombination reaction between two mutant FRT sequences having an identical sequence to each other but does not cause recombination reaction with a wild-type FRT sequence, in the presence of FLP recombinase
06/13/2006US7060498 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
06/13/2006US7060497 Adeno-associated viral vector-based methods and compositions for introducing an expression cassette into a cell
06/13/2006US7060493 used for assays for the detection of Nod2 and Nod2 polymorphisms associated with Crohn's disease and ulcerative colitis
06/13/2006US7060491 Polynucleotides encoding novel BT toxin receptors from lepidopteran insects
06/13/2006US7060483 DNA encoding endo-β-galactosidase
06/13/2006US7060482 Thermostable xylanases
06/13/2006US7060481 Comprises peptide for diagnosing and treating inflammatory, tumor, arthritic and nervous system disorders
06/13/2006US7060480 MRE11 orthologue and uses thereof
06/13/2006US7060479 Full-length human cDNAs encoding potentially secreted proteins
06/13/2006US7060476 Detection modulators of enzyme activity; obtain sample containing enzyme, incubate with binding protein, monitor adjustment in enzyme activity
06/13/2006US7060464 Peptides conferring environmental stress resistance and fusion proteins including said peptides
06/13/2006US7060459 TNF-inducible promoters and methods for using
06/13/2006US7060458 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
06/13/2006US7060457 Diagnosing nervous system disorders in humans; obtain sample, screen for the presence of aberrant glutamate receptor, presence of receptor indicates nervous system disorder
06/13/2006US7060451 Methods for screening GABA-modulatory compounds for specified pharmacological activities
06/13/2006US7060444 Zone 3 necrosis associated markers and method of use thereof
06/13/2006US7060441 Fragmenting the DNA by creating at least one abasic site on DNA, attaching a marker to one of the fragments by means of labeling reagent which is covalently and predominantly coupling to the phosphate of the fragment
06/13/2006US7060439 Apparatus for use as tool in the accurate monitoring of hybridization on microarrays
06/13/2006US7060437 diagnosing abnormal levels of growth hormone activity; sampling brown adipose tissue, assaying messenger RNA, or complementary DNA, correlating that activity with the level of GH activity in brown adipose tissue; diagnostic markers of pathologies of adipose tissue.
06/13/2006US7060436 Detecting the presence of an HIV target sequence
06/13/2006US7060435 screening genomic DNA for the presence or absence of both T-475G and A-147G in the transcriptional regulatory region of CYP3A5; identifying as having a high drug metabolizing phenotype if both variants are present, or having a low metabolizing phenotype if both variants are absent
06/13/2006US7060434 Probes for myctophid fish and a method for developing the same
06/13/2006US7060433 Methods and compositions for screening using diphtheria toxin constructs
06/13/2006US7060432 contacting a yeast sample with yeast specific enzyme-linked probes, hybridizes to form probe/target sequence within; for analysis of beer and liquor
06/13/2006US7060427 Anthraquinone and its derivatives
06/13/2006US7060280 Immunization against flavivirus
06/13/2006US7060276 Plasmodium falciparum AMA-1 protein and uses thereof
06/13/2006US7060275 targets brain tumor protein targets which allow for the selective inhibition of cell function or selective marking for visualization with therapeutic or visualizing compositions which have a specific affinity for these protein targets
06/13/2006US7060272 Death domain containing receptor-4 agonist antibodies and methods
06/13/2006US7060266 Human brain carboxypeptidase B
06/13/2006US7060264 use of patatin and structurally related proteins which have insect inhibitory properties; Coleoptera; monocotyledons;
06/13/2006US7060224 Methods for the electronic, homogeneous assembly and fabrication of devices
06/08/2006WO2006060743A2 Glucose-transport related genes, polypeptides, and methods of use thereof
06/08/2006WO2006060643A2 Novel bladder matrix protein peptides and methods of detection of bladder cancer
06/08/2006WO2006060484A2 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
06/08/2006WO2006060020A1 Sm5-1 antibodies and applications thereof
06/08/2006WO2006059507A1 11β-HSD1 ANTISENSE COMPOUND
06/08/2006WO2006058425A1 Sparc promoter mutations associated with drug resistance, and methods, oligonucleotides, cells and arrays associated therewith
06/08/2006WO2006026738A3 Methods and compositions for rna amplification and detection using an rna-dependent rna-polymerase
06/08/2006WO2006026485A3 Modulation of hif1-beta expression
06/08/2006WO2006017325A3 Aav vector compositions and methods for enhanced expression of immunoglobulins the same
06/08/2006WO2005123963A3 Methods and compositions for use in analyte detection using proximity probes
06/08/2006WO2005121419A3 Rapid and efficient cdna library screening by self-ligation of inverse pcr products
06/08/2006WO2005097818A3 An assay system for screening protease inhibitors
06/08/2006WO2005092069A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/08/2006WO2005089414A3 Neoplasia diagnostic compositions and methods of use
06/08/2006WO2005074599A3 Naphthalimide dosing by n-acetyl transferase genotyping
06/08/2006WO2005059161A3 Methods for evaluation a bacteriophage preparation
06/08/2006WO2005056753A3 Methods of determining juvenile arthritis classification
06/08/2006WO2005052121A3 Multivalent aptamers
06/08/2006WO2005047487B1 Motoneuronotrophic factor gene sequences
06/08/2006WO2005035724A3 Cancer-linked genes as targets for chemotherapy
06/08/2006WO2005027833A3 Compound and method for treating androgen-independent prostate cancer
06/08/2006WO2005023991A3 Small hairpin rna libraries
06/08/2006WO2005014607A3 Antisense modulation of stearoyl-coa desaturase expression
06/08/2006WO2005010197A3 A systemic small rna signaling system in plants
06/08/2006WO2005002527A3 Sirt1 modulation of adipogenesis and adipose function
06/08/2006US20060123511 Plant regulatory sequences for selective control of gene expression
06/08/2006US20060123510 In a sense or antisense orientation, wherein expression results in production of altered levels of the RNA-directed RNA polymerase in a transformed host cell; vectors, transgenic plants; use as tool to control gene expression via cosuppression and to engineer plant virus resistance
06/08/2006US20060123508 plants with nucleotide sequences coding dihydroflavonol reductase (DFR) for generating transgenic plants with increased carbohydrates and nutritional value and which drecrease bloating in animals
06/08/2006US20060123507 Gene elevating cereal yield and utilization thereof
06/08/2006US20060123505 Full-length plant cDNA and uses thereof
06/08/2006US20060123497 Sperm-specific cation channel, catsper-4, and uses therefor
06/08/2006US20060122382 Method of manufacturing labelled oligonucleotide conjugates
06/08/2006US20060122381 Recombinase mediated transcription
06/08/2006US20060122380 Novel human secreted proteins and polynucleotides encoding the same
06/08/2006US20060122376 Protein complexes having factor VIII:C activity and production thereof
06/08/2006US20060122375 Plant stress tolerance genes, and uses therefor
06/08/2006US20060122373 Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof
06/08/2006US20060122372 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications
06/08/2006US20060122143 Drug-eluting stents coated with P2Y12 receptor antagonist compound
06/08/2006US20060122137 5'-methylpyrimidine and 2'-O-methyl ribonucleotide modified double-stranded ribonucleic acid molecules
06/08/2006US20060122136 Effective and stable DNA enzymes
06/08/2006US20060122135 Cloning and expression of a novel member of the Glial cell-line derived neurotrophic factors (GDNF); Parkinson's , Alzheimer's , Huntington's, Creutzfeld-Jacob diseases, neuropathic pain; acute brain injury, multiple sclerosis, amyotrophic lateral sclerosis, peripheral nerve trauma; cancer
06/08/2006US20060122134 double-stranded decoy oligonucleotide; atherosclerosis; acts as a competitive inhibitor (or rather neutralisation) of a natural core-binding sequence of a DNA-binding protein or protein complex thereby blocks the expression of the eNOS
06/08/2006US20060122133 Antisense modulation of vegf co-regulated chemokine-1 expression
06/08/2006US20060122132 Use of murine genomic regions identified to be involved in tumor developement for the development of anti-cancer drugs and diagnosis of cancer
06/08/2006US20060121588 Process for the biological production of 1,3-propanediol with high titer
06/08/2006US20060121581 Production of bacterial strains cross reference to related applications
06/08/2006US20060121577 Comprises polynucleotides coding proteins associated with generating macrolide antibiotics; bactericides; polyketide synthase
06/08/2006US20060121576 Maltose-1-phosphate-producing enzyme
06/08/2006US20060121574 Recombinant method for making multimeric proteins
06/08/2006US20060121572 Production of heterologous proteins in Caulobacter
06/08/2006US20060121571 encode a polypeptide having oxalate degrading activity
06/08/2006US20060121570 Methods for producing polypeptide binding sites, monoclonal antibodies and compositions thereof
06/08/2006US20060121566 Stem cell expansion factor blocking gene limiting hox-induced expansion and method using such factor
06/08/2006US20060121565 Methods for increasing the production of a recombinant polypeptide from a host cell
06/08/2006US20060121563 Novel tricistronic vectors and uses therefor
06/08/2006US20060121562 Human receptor tyrosine kinase mertk
06/08/2006US20060121561 Gene for increased somatic recombination